(Not Sponsored by Layer Origin)
(Not Sponsored by Layer Origin)
(Not Sponsored by Layer Origin)
Data Source: Kostopoulos, Ioannis, et al. "Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro." Scientific reports 10.1 (2020): 14330. (Not Sponsored by Layer Origin)
Data Source: Castillo‐Courtade, L., et al. "Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model." Allergy 70.9 (2015): 1091-1102. (Not Sponsored by Layer Origin)
Data Source: Bajic, Danica, et al. "HMOs Impact the Gut Microbiome of Children and Adults Starting from Low Predicted Daily Doses." Metabolites 14.4 (2024): 239. (Not Sponsored by Layer Origin)
Data Source: Yoshida, Erina, et al. "Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides." Glycobiology 22.3 (2012): 361-368. (Not Sponsored by Layer Origin)
Data Source: Palsson, Olafur S., et al. "Human milk oligosaccharides support normal bowel function and improve symptoms of irritable bowel syndrome: a multicenter, open-label trial." Clinical and translational gastroenterology 11.12 (2020): e00276. (Independent, not sponsored by Layer Origin)
Data Source: Iribarren, Cristina, et al. "Human milk oligosaccharide supplementation in irritable bowel syndrome patients: A parallel, randomized, double‐blind, placebo‐controlled study." Neurogastroenterology & Motility 32.10 (2020): e13920. (Independent, not sponsored by Layer Origin):
Data Source: (Independent, not sponsored by Layer Origin)